Patrick Burnett, MD, PhD, Chief Medical Officer at Arcutis Bioteheraputics, discusses the promise of the company’s roflumilast cream for AD.
Patrick Burnett, MD, PhD, Chief Medical Officer at Arcutis Bioteheraputics, discusses the promise of the company’s roflumilast cream for AD.